AN UNBIASED VIEW OF RETATRUTIDE

Semaglutide has long been shown to bring about medullary thyroid cell carcinoma in rodents. Although its clinical relevance to people is unknown, the FDA advises never to administer this drug in those with a personal or spouse and children heritage of medullary thyroid carcinoma. Semaglutide also poses a hazard of pancreatitis and dehydration.When